Enantiomeric Separation and Sensitive Detection of Propranolol, Metoprolol and Atenolol Derivatized With a Fluorogenic Reagent, 4-(N-Chloroformylmethyl-N- methyl)amino-7-N,N-dimethylaminosulfonyl-2,1,3- benzoxadiazole (DBD-COCl), on Cellulose Chiral Columns in the Reversed-phase Mode

Abstract

An electrophilic fluorogenic reagent, 4-(N- chloroformylmethyl-N-methyl)amino-7-N,N- dimethylaminosulfonyl-2,1,3-benzoxadiazole (DBD-COCl), was used to react with three β-blockers, propranolol, metoprolol and atenolol, to yield the derivatives which were subsequently verified to be amide compounds (1:1 adducts) derived from the reaction with the secondary amino group of the β-blockers. DBD-COCl exhibited high reactivity for the reaction completed within 5 min under mild conditions and without any need for a catalyst. The derivatives were well separated enantiomerically on cellulose CSPs (the derivative of propranolol on a Chiralcel OD-R column and those of metoprolol and atenolol on a Chiralcel OJ-R column) in the reversed-phase mode, with the S-configurations being eluted before the R-configurations. The derivatives were stable at 4°C for 1 week. The detection limits (S/N = 3) were 50 fmol for both (S)- and (R)-propranolol, 12 and 17 fmol for (S)- and (R)-metoprolol, respectively, and 15 and 20 fmol for (S)- and (R)-atenolol, respectively.

References

1. R. Howe and R. G. Shanks, Nature (London), 1966, 210, 1336.
2. T. Walle, J. G. Webb, E. E. Bagwell, U. K. Walle, H. B. Daniell and T. E. Gaffney, Biochem. Pharmacol., 1988, 37, 115.
3. G. Egginger, W. Lindner, C. Vandenbosh and D. L. Massart, Biomed. Chromatogr., 1993, 7, 277.
4. W. A. Clementi, T. Q. Garvey, G. D. Clifton, R. A. McCoy, S. Brandt and S. Schwartz, Chirality, 1994, 6, 169.
5. K. Stoschitzky, S. Kahr, J. Donnerer, M. Schumacher, O. Luda, R. Maier, W. Klein and W. Lindner, Clin. Pharmacol. Ther., 1995, 57, 543.
6. Y. Okamoto, M. Kawashima, R. Aburatani, K. Hatada, T. Nashigawa and M. Masuda, Chem. Lett., 1986, 1237.
7. V. L. Herring, T. L. Bastian and R. L. Lalonde, J. Chromatogr., 1991, 567, 221.
8. R. J. Straka, K. A. Johnson and P. S. Marshall, J. Chromatogr., 1990, 530, 83.
9. D. R. Rutledge and C. Garrick, J. Chromatogr., 1989, 497, 181.
10. M. S. Ching, M. S. Lennard, A. Gregory and G. T. Tucker, J. Chromatogr., 1989, 497, 313.
11. V. L. Herring and J. A. Johnson, J. Chromatogr., 1993, 612, 215.
12. H. Y. Aboul-Enein and V. Serigness, J. Liq. Chromatogr., 1993, 16, 197.
13. H. Y. Aboul-Enein and V. Serigness, Biomed. Chromatogr., 1994, 8, 22.
14. A. Ishikawa and T. Shibata, J. Liq. Chromatogr., 1993, 16, 859.
15. T. Fukushima, T. Santa, H. Homma, S. Al-kindy and K. Imai, Anal. Chem., 1997, 69, 1793.
16. K. Imai, T. Fukushima and H. Yokosu, Biomed. Chromatogr., 1994, 8, 107.
17. Y. Okamoto, R. Aburatani, K. Hatano and K. Hatada, J. Liq. Chromatogr., 1988, 11, 2147.
18. X. Yang, Y. Hu, G. Wang and X. Tu, Acta Pharm. Sini., 1990, 25, 457.
19. B. Kofahl, D. Henke and E. Mutschler, Chirality, 1993, 5, 479.
20. Y. Okamoto, M. Kawashima and K. Hatada, J. Chromatogr., 1986, 363, 173.
21. E. Yashima, M. Yamada, Y. Kaida and Y. Okamoto, J. Chromatogr. A, 1995, 694, 347.
22. E. Yashima and Y. Okamoto, Bull. Chem. Soc. Jpn., 1995, 68, 3289.
23. E. Yashima, C. Yamamoto and Y. Okamoto, J. Am. Chem. Soc., 1996, 118, 4036.
24. K. Balmér, B.-A. Persson and G. Schill, J. Chromatogr., 1989, 477, 107.
25. B.-A. Persson, K. Balmér and P.-O. Lagerström, J. Chromatogr., 1990, 500, 629.
26. R. Büschges, R. Devant, E. Mutschler and H. Spahn-Lagguth, J. Pharm. Biomed. Anal., 1996, 15, 193.